Prevalence of Ticarcillin/Clavulanic Acid-Resistant Enterobacteriacaeae in Nine Separate Medical Centers During the Years 1983, 1989, and 1991
Reference11 articles.
1. A.L. Barry, Antistaphylococcal activity of amoxicillin and ticarcillin when combined with clavulanic acid, evaluation of oxacillin-resistant and oxacillin-susceptible isolates. Diagn. Microbiol. Infect. Dis. 13:357–361 (1990).
2. A.L. Barry, L.W. Ayers, T.L. Gavan, E.H. Gerlach, and R.N. Jones, In vitro activity of ticarcillin plus clavulanic acid against bacteria isolated in three centers, Eur. J. Clin. Microbiol., 3:203–206 (1984).
3. A.L. Barry, P.C. Fuchs, E.H. Gerlach, D.J. Hardy, J.C. McLaughlin, and MA Pfaller, Ticarcillin and ticarcillin/clavulanic acid susceptibility tests: error rates for disk tests with consecutively isolated Enterbacteriaceae, Antimicrob. Agents Chemother., 36:137–143 (1992).
4. A.L. Barry, C. Thornsberry, R.N. Jones, and T.L. Gavan, In vitro activity of mezlocillin and azlocillin compared to that of four other penicillins and two aminoglycosides. Cleveland Clinic Quarterly 47:311–319 (1980).
5. P.C. Fuchs, A.L. Barry, and R.N. Jones, In vitro activity and disk susceptibility of Timentin: current status, Amer. J. Med. 79 Suppl 5B:25–32 (1985).